EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Facilitators and barriers to adolescent participation in a TB clinical trial

J M Mangan, K N C Hedges, M M Salerno, K Tatum, B Bouwkamp, M W Frick, L McKenna, G Muzanyi, M Engle, J Coetzee, J Yvetot, M Elskamp und 8 weitere

The International Journal of Tuberculosis and Lung Disease · 01.05.2024 · 28 (5) · 243-248

DOI: 10.5588/ijtld.23.0519 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 01.05.2024. Verfasst von J M Mangan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Tuberculosis Elimination, Centers for Disease Control, Atlanta, GA. Hauptthemen laut MEDLINE: Patient Selection, Focus Groups, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND

The inclusion of adolescents in TB drug trials is essential for the development of safe, child-friendly regimens for the prevention and treatment of TB. TB Trials Consortium Study 31/AIDS Clinical Trials Group A5349 (S31/A5349) enrolled adolescents as young as 12 years old. We assessed investigator and coordinator described facilitators and barriers to adolescent recruitment, enrollment, and retention.





METHODS

Interviews were conducted with six investigators from sites that enrolled adolescent participants and six investigators from non-enrolling sites. Additionally, two focus groups were conducted with study coordinators from enrolling sites and two focus groups with non-enrolling sites. Discussions were transcribed, analyzed, summarized, and summaries were reviewed by Community Research Advisors Group members and research group representatives for content validity.





RESULTS

Investigators and coordinators attributed the successful enrollment of adolescents to the establishment and cultivation of external partnerships, flexibility to accommodate adolescents’ schedules, staff engagement, recruitment from multiple locations, dedicated recruitment staff working onsite to access potential participants, creation of youth-friendly environments, and effective communications. Non-enrolling sites were mainly hindered by regulations. Suggestions for improvement in future trials focused on study planning and site preparations.





CONCLUSION

Proactive partnerships and collaboration with institutions serving adolescents helped identify and reduce barriers to their inclusion in this trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient SelectionFocus GroupsTuberculosisHumansAdolescentFemaleMaleChildAntitubercular AgentsClinical Trials as TopicResearch Personnel

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Division of Tuberculosis Elimination, Centers for Disease Control, Atlanta, GA.
  • Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, NY.
  • Division of Tuberculosis Elimination, Centers for Disease Control, Atlanta, GA, Oak Ridge Institute for Science and Education.
  • Treatment Action Group, New York, NY, USA.
  • Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda.
  • UTHSCSA & San Antonio Veterans Administration Medical Center, TX, USA.

Förderung

  • NIAID NIH HHS
  • Intramural CDC HHS

Zitieren

APA

Mangan, J. M., Hedges, K. N. C., Salerno, M. M., Tatum, K., Bouwkamp, B., Frick, M. W., McKenna, L., Muzanyi, G., Engle, M., Coetzee, J., Yvetot, J., Elskamp, M., Lamunu, D., Tizora, M. E. T., Namutamba, D., Chaisson, R. E., Swindells, S., Nahid, P., Dorman, S. E., & Kurbatova, E. (2024). Facilitators and barriers to adolescent participation in a TB clinical trial. The International Journal of Tuberculosis and Lung Disease, 28(5), 243-248. https://doi.org/10.5588/ijtld.23.0519

Vancouver

Mangan JM, Hedges KNC, Salerno MM, Tatum K, Bouwkamp B, Frick MW, et al. Facilitators and barriers to adolescent participation in a TB clinical trial. The International Journal of Tuberculosis and Lung Disease. 2024;28(5):243-248. doi:10.5588/ijtld.23.0519

BibTeX
@article{Mangan2024,
  author = {Mangan, J M and Hedges, K N C and Salerno, M M and Tatum, K and Bouwkamp, B and Frick, M W and McKenna, L and Muzanyi, G and Engle, M and Coetzee, J and Yvetot, J and Elskamp, M and Lamunu, D and Tizora, M E Theunissen and Namutamba, D and Chaisson, R E and Swindells, S and Nahid, P and Dorman, S E and Kurbatova, E},
  title = {Facilitators and barriers to adolescent participation in a TB clinical trial},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2024},
  volume = {28},
  number = {5},
  pages = {243--248},
  doi = {10.5588/ijtld.23.0519}
}
Kostenlos starten →